Hybrid Immunity Provides Protective Advantage Over Vaccination or Prior Remote Coronavirus Disease 2019 Alone

BACKGROUND: The protective efficacy of prior coronavirus disease 2019 (COVID-19) with or without vaccination remains unknown. This study sought to understand if 2 or more messenger RNA (mRNA) vaccine doses provide additional protection in patients with prior infection, or if infection alone provides...

Descripción completa

Detalles Bibliográficos
Autores principales: Virk, Abinash, Johnson, Matthew G, Roellinger, Daniel L, Scott, Christopher G, Sampathkumar, Priya, Breeher, Laura E, Swift, Melanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167982/
https://www.ncbi.nlm.nih.gov/pubmed/37180597
http://dx.doi.org/10.1093/ofid/ofad161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167982/
https://www.ncbi.nlm.nih.gov/pubmed/37180597
http://dx.doi.org/10.1093/ofid/ofad161

Ejemplares similares